NDIR CO2 Sensor Protects Workers Throughout Cold Supply Chain of Covid-19 Vaccine

The Cranberry NDIR CO2 sensor integrated into the Honeywell BW™ SOLO CO2 product has become essential for workers' protection when manipulating large volumes of dry ice By DA Staff / 15 Jan 2021

Dry ice, frozen carbon dioxide (CO2), maintains the Covid-19 vaccines at very low temperatures. As dry ice warms and changes from a frozen to a gaseous state, it creates an excessive presence of CO2 gas which could affect the health of workers.

The Cranberry NDIR (Non-Dispersive-Infra-Red) CO2 sensor from eLichens is designed to serve such critical applications.

By continuously monitoring CO2 levels and triggering alerts when high thresholds are exceeded, the Cranberry NDIR CO2 sensor integrated into the Honeywell BW™ SOLO CO2 product has become essential for workers’ protection when manipulating large volumes of dry ice as it prevents toxic health effects such as asphyxia, dizziness, disorientation, fatigue and convulsions.

“We are very proud that eLichens CO2 sensor has been selected by Honeywell for their BW™ SOLO CO2 product to monitor and alert workers in case of unsafe conditions and minimize disruptions throughout the Covid-19 vaccine cold supply chain,” said Wahid Issa, Chief Executive Officer of eLichens.

eLichens’ Cranberry 1-series NDIR sensor is the smallest industrial grade CO2 sensor on the market. It is high performance, dual channel and ultra-low power.

“Working closely with eLichens we quickly saw the technical benefits of their technology and that this was a great fit for our BW™ SOLO CO2 product giving us a sensor that performs in extreme conditions and a reliability that the end user can trust,” said Richard Dunn, Senior Offering Management Leader at Honeywell.

Posted by DA Staff Connect & Contact

Keep up to date with the latest news and
technical developments in Unmanned Systems.

Sign up to the UST weekly eBrief

By clicking "Sign me up" I consent to my personal information being processed for the purpose of sending me the 'eBrief' weekly e-newsletter. See our Website privacy policy.